Location: Home
  • search
  • go
  • Relate News
  • 1/12/2026Eli Lilly Submits Orforglipron NDA in China for GLP-1R Agonist
  • 1/12/2026Anticancer Bioscience Secures Angel Funding to Advance Precision Oncol...
  • 1/9/2026MediLink and Roche Expand Partnership with Exclusive Global License fo...
  • 1/9/2026Hengrui Secures China Approval for Retlirafusp Alfa for Gastric Cancer
  • 1/9/2026China Issues New Procedures for Post-Approval Filing Changes to Overse...
  • 1/9/2026NHSA Seeks Comments on Draft Rules for Early Communication on Comparat...
  • 1/9/2026China Expands Cross-Province Use of Employee BMI Funds for Family Memb...
  • 1/9/2026China Rolls Out Smart Medical Insurance Payments to Improve Access
  • 1/9/2026Recent Executive Moves
  • 1/9/2026AirNexis Launches with $200M to Advance China-Origin COPD Therapy
  • 1/8/2026Alumis Reports Positive Phase 3 Results for Envudeucitinib in Plaque P...
  • 1/8/2026China Convenes National Health Work Conference to Outline 2026 Priorit...
  • 1/8/2026NMPA Moves to Accelerate Approval of Overseas-Approved Drugs for Urgen...
  • 1/8/2026NMPA Clarifies Application of ICH Q12 to Strengthen Pharmaceutical Lif...
  • 1/8/2026China to Implement ICH E6(R3) Guideline for Drug Clinical Trial Qualit...
  • 1/8/2026Curium's IND for 177Lu-PSMA-I&T Accepted for Review in China
  • 1/8/2026China's Pet Obesity Sparks Biotech Race for Weight-Loss Drugs
  • 1/8/2026Sinovac Secures Exclusive 2026 Influenza Vaccine Supply Contract with ...
  • 1/8/2026AskBio Receives FDA Acceptance of IND for AB-1009 Gene Therapy
  • 1/8/2026HUTCHMED Reports Positive Phase III Results for Sovleplenib in China
  • 1/8/2026BioRay Files for Hong Kong IPO to Advance Innovative Biologics Portfol...
  • 1/8/2026Hengrui Wins China Approval for Retlirafusp Alfa
  • 1/8/2026China Revises Drug Administration Law Implementation Rules to Boost In...
  • 1/8/2026China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...
  • 1/8/2026Luye's Ruoxinlin NDA Accepted in China for Anxiety Disorder Treatment
  • 1/8/2026Hansoh Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
  • 1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC
  • 1/8/2026Chinese Drug Makers Hit Record US$136B in Global Out-Licensing Deals i...
  • 1/8/2026Asia Emerges as the New Epicenter of Global Biopharma Innovation: McKi...
  • 1/7/2026Epigenic Advances FIC Epigenetic HBV Therapy With U.S. IND Clearance
  • Page:18/827 Total number of articles:24804: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group